Within just two years of reaching a milestone of 2,500 employees, SHL Group has rapidly reached 3,000 employees worldwide. This increase is reflective of a steady yet rapid growth in the injectable drug delivery market and SHL’s effective commitment, productivity and management.
A global leader in the design and manufacturing of auto injectors and pen injectors, SHL offers innovative designs, robust manufacturing capabilities, a lean supply chain, strong partnerships, and more. With offices and manufacturing facilities located in Taiwan, Sweden, USA and China, SHL aims for the highest product and service quality, better brand recognition, and building of business values for employees and customers.
Over the years, SHL has continuously invested in R&D and manufacturing capabilities, and currently houses more than 180 high precision molding machines selected from leading brands such as Krauss Maffei, Engel and Netstal. With expert engineers operating such state-of-the-art equipment, SHL has been able to meet increasing customer demands for response time, quality and capacity.
“SHL is committed to developing innovative devices and providing exceptional customer service, thus we never hesitate when it comes to further investments and expansions if it means providing better quality and capacity for our customers,” said Roger Samuelsson, President & CEO of SHL Group. “We have been extending and expanding our services and production sites over the years, and will continue to do so to accommodate future needs. Reaching 3,000 employees in such a short time is a true milestone for us and we look forward to bringing more leading-edge technology to market in such areas as auto injectors and pen injectors, inhalers, connectivity and much more.”
At present, SHL works with 80% of the world’s top 25 pharmaceutical companies and expands across Sweden, USA, Taiwan and China. Currently there are nine major production sites in Taiwan.
SHL is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next-generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
With over 3,700 staff worldwide, our organization consists of several distinct group companies:
SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe
SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl.group